TY - JOUR
T1 - Imprinted Dlk1 dosage as a size determinant of the mammalian pituitary gland
AU - Scagliotti, Valeria
AU - Vignola, Maria Lillina
AU - Willis, Thea
AU - Howard, Mark
AU - Marinelli, Eugenia
AU - Gaston-Massuet, Carles
AU - Andoniadou, Cynthia
AU - Charalambous, Marika
N1 - Funding Information:
We thank Prof Anne Ferguson-Smith, University of Cambridge for the TGDlk1-70C mouse line. Funding was provided by the Medical Research Council (MRC) Grants MR/L002345/1 (MC), MR/R022836/1 (MC) and MR/T012153/1 (CLA), the Merck 2020 Grant for Growth Innovation (MC), and the Society for Endocrinology, UK (MH). MLV was supported by a studentship from the NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London. TLW was funded by King’s College London as part of the “Cell Therapies and Regenerative Medicine” Four-Year Welcome Trust PhD Training Program. CGM was sponsored by Action Medical Research (GN2272) and Barts Charity (GN 417/2238 & MGU0551).
Publisher Copyright:
© Scagliotti et al.
PY - 2023
Y1 - 2023
N2 - Co-regulated genes of the Imprinted Gene Network are involved in the control of growth and body size, and imprinted gene dysfunction underlies human paediatric disorders involving the endocrine system. Imprinted genes are highly expressed in the pituitary gland, among them, Dlk1, a paternally expressed gene whose membrane-bound and secreted protein products can regulate proliferation and differentiation of multiple stem cell populations. Dosage of circulating DLK1 has been previously implicated in the control of growth through unknown molecular mechanisms. Here we generate a series of mouse genetic models to modify levels of Dlk1 expression in the pituitary gland and demonstrate that the dosage of DLK1 modulates the process of stem cell commitment with lifelong impact on pituitary gland size. We establish that stem cells are a critical source of DLK1, where embryonic disruption alters proliferation in the anterior pituitary, leading to long-lasting consequences on growth hormone secretion later in life.
AB - Co-regulated genes of the Imprinted Gene Network are involved in the control of growth and body size, and imprinted gene dysfunction underlies human paediatric disorders involving the endocrine system. Imprinted genes are highly expressed in the pituitary gland, among them, Dlk1, a paternally expressed gene whose membrane-bound and secreted protein products can regulate proliferation and differentiation of multiple stem cell populations. Dosage of circulating DLK1 has been previously implicated in the control of growth through unknown molecular mechanisms. Here we generate a series of mouse genetic models to modify levels of Dlk1 expression in the pituitary gland and demonstrate that the dosage of DLK1 modulates the process of stem cell commitment with lifelong impact on pituitary gland size. We establish that stem cells are a critical source of DLK1, where embryonic disruption alters proliferation in the anterior pituitary, leading to long-lasting consequences on growth hormone secretion later in life.
UR - http://www.scopus.com/inward/record.url?scp=85169176889&partnerID=8YFLogxK
U2 - 10.7554/eLife.84092
DO - 10.7554/eLife.84092
M3 - Article
C2 - 37589451
AN - SCOPUS:85169176889
SN - 2050-084X
VL - 12
JO - eLife
JF - eLife
M1 - e84092
ER -